Skip to content
Search

Latest Stories

NPA Chair to COVID-19 Inquiry: ‘A resilient pharmacy network’ crucial for future pandemic response

NPA Chair to COVID-19 Inquiry: ‘A resilient pharmacy network’ crucial for future pandemic response

Nick Kaye urged the COVID-19 Inquiry to recognise community pharmacists and their teams as “a genuine part of the NHS family”  

Nick Kaye, chair of the National Pharmacy Association (NPA), gave evidence to the UK’s official COVID-19 Inquiry on Monday (4 November), highlighting the importance of building a “sustainable and resilient community pharmacy network” to enhance preparedness for future pandemics.


Kaye also recommended utilising the existing community pharmacy infrastructure for public health initiatives, such as vaccination programmes, and stressed the need to recognise community pharmacists and their teams as integral members of primary care.

“Seven pharmacies a week are closing across the four nations, and that is tragic for any future response. So, a resilient community pharmacy network that exists is going to be key,” he told the Inquiry.

He noted that 90 per cent of most NPA members' income comes from providing NHS services, underscoring the critical role pharmacies play in healthcare delivery.

However, Kaye highlighted that pharmacies were often overlooked and underappreciated during the pandemic.

He noted that when the pandemic hit the UK in 2020, pharmacies faced significant challenges, including the inability to access personal protective equipment (PPE) from the NHS stock and limited access to vaccines for pharmacy staff compared to other healthcare professionals.

Additionally, pharmacy staff were initially excluded from the death-in-service compensation scheme specially created for NHS workers.

Kaye called for pharmacies to be “reframed” in the minds of policy makers as “a genuine part of the NHS family” so that the same mistakes would not be repeated in future crises.

Reflecting on the vital role community pharmacies played during the national emergency, Kaye described them as the “shock-absorbers” for the healthcare system.

After hearing Kaye’s testimony, the Inquiry’s chair, Baroness Hallett, praised pharmacies for their “superb work” during the pandemic.

“I’m sorry you [pharmacies] didn’t get the recognition at the time that you should have done,” she said.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less